Gyros AB Appoints Dr. Claus Braestrup to the Board of Directors
News Jan 28, 2013
He is also a Member of the Advisory Board of Nordic Biotech and BankInvest BioMedical Venture. Dr. Braestrup is a Member of The Royal Danish Scientific Society and The Academy of Technical Sciences. He holds M.Sc. degrees in Chemical Engineering and Biochemistry, and a Doctorate in Medical Science from the University of Copenhagen.
Dr. Braestrup was previously President and Chief Executive Officer at H. Lundbeck A/S. He also formerly held the positions of Vice President of Pharmaceutical Research, President of the CNS Division, and President of the Diabetes Care Division at Novo Nordisk A/S, and Head of Preclinical Drug Research with Schering AG.
Erik Walldén, CEO at Gyros, commented: “We welcome Claus to the Board of Directors. His excellent scientific background and many years’ experience within the biotech and pharmaceutical industry will be a great asset to Gyros.”
Diagnosing Immunity to Ebola With Paper Tests & SmartphonesNews
A promising new approach to detect immunity to Ebola virus infection has been developed by researchers from i-sense in a collaboration between UCL and Imperial College London.READ MORE
New Technique Eases Production, Customization of Soft RoboticsNews
By helping rubber and plastic stick together under pressure, University of Nebraska-Lincoln chemists have simplified the production of small fluid-carrying channels that can drive movement in soft robotics and enable chemical analyses on microscopic scales.READ MORE
New Preservation Method Maintains Viable CTCs for up to 72 HoursNews
A new blood stabilization method significantly prolongs the lifespan of blood samples for microfluidic sorting and transcriptome profiling of rare circulating tumor cells.READ MORE